documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
29 rows where docket_id = "FDA-2020-N-0258" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-0258-0016 | FDA | None FDA-2020-N-0258 | PRIA Reference 7 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:58:39Z | 0 | 0 | 090000648552f2ed | |||
| FDA-2020-N-0258-0020 | FDA | None FDA-2020-N-0258 | PRIA Reference 11 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:47:36Z | 0 | 0 | 090000648552f2f1 | |||
| FDA-2020-N-0258-0028 | FDA | None FDA-2020-N-0258 | PRIA Reference 19 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:59:48Z | 0 | 0 | 090000648552f2fa | |||
| FDA-2020-N-0258-0002 | FDA | None FDA-2020-N-0258 | Reference 1 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:16Z | 0 | 0 | 090000648552f118 | |||
| FDA-2020-N-0258-0009 | FDA | None FDA-2020-N-0258 | Reference 8 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:44Z | 0 | 0 | 090000648552f11f | |||
| FDA-2020-N-0258-0012 | FDA | None FDA-2020-N-0258 | PRIA Reference 3 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:53:57Z | 0 | 0 | 090000648552f2e9 | |||
| FDA-2020-N-0258-0015 | FDA | None FDA-2020-N-0258 | PRIA Reference 6 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:57:41Z | 0 | 0 | 090000648552f2ec | |||
| FDA-2020-N-0258-0019 | FDA | None FDA-2020-N-0258 | PRIA Reference 10 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:50:53Z | 0 | 0 | 090000648552f2f0 | |||
| FDA-2020-N-0258-0021 | FDA | None FDA-2020-N-0258 | PRIA Reference 12 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:49:09Z | 0 | 0 | 090000648552f2f2 | |||
| FDA-2020-N-0258-0005 | FDA | None FDA-2020-N-0258 | Reference 4 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:28Z | 0 | 0 | 090000648552f11b | |||
| FDA-2020-N-0258-0006 | FDA | None FDA-2020-N-0258 | Reference 5 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:33Z | 0 | 0 | 090000648552f11c | |||
| FDA-2020-N-0258-0014 | FDA | None FDA-2020-N-0258 | PRIA Reference 5 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:56:20Z | 0 | 0 | 090000648552f2eb | |||
| FDA-2020-N-0258-0018 | FDA | None FDA-2020-N-0258 | PRIA Reference 9 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:06:20Z | 0 | 0 | 090000648552f2ef | |||
| FDA-2020-N-0258-0027 | FDA | None FDA-2020-N-0258 | PRIA Reference 18 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:58:37Z | 0 | 0 | 090000648552f2f9 | |||
| FDA-2020-N-0258-0004 | FDA | None FDA-2020-N-0258 | Reference 3 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:24Z | 0 | 0 | 090000648552f11a | |||
| FDA-2020-N-0258-0007 | FDA | None FDA-2020-N-0258 | Reference 6 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:37Z | 0 | 0 | 090000648552f11d | |||
| FDA-2020-N-0258-0022 | FDA | None FDA-2020-N-0258 | PRIA Reference 13 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:51:58Z | 0 | 0 | 090000648552f2f4 | |||
| FDA-2020-N-0258-0024 | FDA | None FDA-2020-N-0258 | PRIA Reference 15 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:55:29Z | 0 | 0 | 090000648552f2f6 | |||
| FDA-2020-N-0258-0026 | FDA | None FDA-2020-N-0258 | PRIA Reference 17 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:57:35Z | 0 | 0 | 090000648552f2f8 | |||
| FDA-2020-N-0258-0010 | FDA | None FDA-2020-N-0258 | PRIA Reference 1 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:51:51Z | 0 | 0 | 090000648552f2dc | |||
| FDA-2020-N-0258-0017 | FDA | None FDA-2020-N-0258 | PRIA Reference 8 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:04:04Z | 0 | 0 | 090000648552f2ee | |||
| FDA-2020-N-0258-0023 | FDA | None FDA-2020-N-0258 | PRIA Reference 14 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:53:57Z | 0 | 0 | 090000648552f2f5 | |||
| FDA-2020-N-0258-0003 | FDA | None FDA-2020-N-0258 | Reference 2 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:20Z | 0 | 0 | 090000648552f119 | |||
| FDA-2020-N-0258-0011 | FDA | None FDA-2020-N-0258 | PRIA Reference 2 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:52:46Z | 0 | 0 | 090000648552f2dd | |||
| FDA-2020-N-0258-0013 | FDA | None FDA-2020-N-0258 | PRIA Reference 4 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T16:55:08Z | 0 | 0 | 090000648552f2ea | |||
| FDA-2020-N-0258-0025 | FDA | None FDA-2020-N-0258 | PRIA Reference 16 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T17:56:25Z | 0 | 0 | 090000648552f2f7 | |||
| FDA-2020-N-0258-0029 | FDA | None FDA-2020-N-0258 | PRIA Reference 20 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T18:00:44Z | 0 | 0 | 090000648552f2fb | |||
| FDA-2020-N-0258-0008 | FDA | None FDA-2020-N-0258 | Reference 7 re: Investigational New Drug Application Annual Reporting | Supporting & Related Material | Background Material | 2022-12-12T05:00:00Z | 2022 | 12 | 2022-12-12T15:09:41Z | 0 | 0 | 090000648552f11e | |||
| FDA-2020-N-0258-0001 | FDA | None FDA-2020-N-0258 | Investigational New Drug Application Annual Reporting | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2022-12-09T05:00:00Z | 2022 | 12 | 2022-12-09T05:00:00Z | 2023-03-10T04:59:59Z | 2023-03-31T01:01:11Z | 2022-26731 | 0 | 0 | 090000648552a78a |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;